InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1 |
TZYWCYJVHRLUCT-VABKMULXSA-N |
C([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)=O)=O)(=O)[H] |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
proteasome inhibitor
A drug that blocks the action of proteasomes, cellular complexes that break down proteins.
|
|
N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-4-methyl-1-oxopentan-2-yl]-L-leucinamide
|
(S)-N-((phenylmethoxy)carbonyl)-L-leucyl-N-(1-formyl-3-methylbutyl)-L-leucinamide
|
ChemIDplus
|
benzyloxycarbonyl-leu-leu-leu-aldehyde
|
ChemIDplus
|
benzyloxycarbonyl-leucyl-leucyl-leucinal
|
ChemIDplus
|
benzyloxycarbonylleucyl-leucyl-leucine aldehyde
|
ChemIDplus
|
carbobenzoxy-Leu-Leu-leucinal
|
ChEBI
|
carbobenzoxy-leucyl-leucyl-leucinal
|
ChemIDplus
|
carbobenzoxyl-leucinyl-leucinyl-leucinal-H
|
ChemIDplus
|
Cbz-L-Leu-L-Leu-L-Leu-CHO
|
ChEBI
|
Cbz-L-Leu-L-Leu-L-Leu-H
|
ChEBI
|
Cbz-Leu-Leu-Leu-CHO
|
ChEBI
|
Cbz-Leu-Leu-Leu-H
|
ChEBI
|
Cbz-Leu-Leu-Leucinal
|
ChEBI
|
MG 132
|
ChemIDplus
|
MG-132
|
ChemIDplus
|
Z-Leu-Leu-Leu-al
|
ChemIDplus
|
Z-Leu-Leu-Leu-CHO
|
ChEBI
|
Z-Leu-Leu-Leu-H
|
ChEBI
|
Z-Leu-Leu-Leucinal
|
ChemIDplus
|
Z-LLL-CHO
|
ChEBI
|
Z-LLL-H
|
ChEBI
|
Z-LLLal
|
ChemIDplus
|
ZLLL-CHO
|
ChemIDplus
|
ZLLLal
|
ChemIDplus
|